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Abstract
Background: It remains debated how much fluid should be administered during surgery. The atrial natriuretic
peptide precursor proANP is released by atrial distension and deviations in plasma proANP are reported associated
with perioperative fluid balance. We hypothesized that plasma proANP would decrease when the central blood
volume is compromised during the abdominal part of robot-assisted hybrid (RE) esophagectomy and that a
positive fluid balance would be required to maintain plasma proANP.
Methods: Patients undergoing RE (n = 25) or open (OE; n = 25) esophagectomy for gastroesophageal cancer were
included consecutively in this prospective observational study. Plasma proANP was determined repetitively during
esophagectomy to allow for distinction between the abdominal and thoracic part of the procedure. The RE group
was 15° head up tilted during the abdominal procedure.
Results: The blood loss was 250 (150–375) (RE) and 600 ml (390–855) (OE) (p = 0.01), but the two groups of
patients were provided with a similar positive fluid balance: 1705 (1390–1983) vs. 1528 ml (1316–1834) (p = 0.4).
However, plasma proANP decreased by 21% (p < 0.01) during the abdominal part of RE carried out during
moderate head-up tilt, but only by 11% (p = 0.01) during OE where the patients were supine. Plasma proANP and
fluid balance were correlated in the RE-group (r = 0.5 (0.073–0.840), p = 0.02) and tended to correlate in the OE
group (r = 0.4 (−0.045–0.833), p = 0.08).
Conclusion: The results support that plasma proANP decreases when the central blood volume is compromised
and suggest that an about 2200 ml surplus administration of crystalloid is required to maintain plasma proANP
during esophagectomy.
Trial registration: Clinicaltrials.gov (NCT02077673). Registered retrospectively February 12th 2014.
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Background
Fluid administration affects outcome after surgery [1–3],
but it remains debated how much fluid should be ad-
ministered and how the volume load is to be evaluated
[4, 5]. For colorectal surgery a “restricted” fluid regimen
seems profitable in regard to cardiopulmonary complica-
tions and tissue healing [3, 6]. On the other hand, patients
going through laparoscopic cholecystectomy appear to
benefit from a “liberal” fluid regimen [1], probably because
the patients are head-up tilted. Deviations in postoperative
outcome relate likely to how well the central blood vol-
ume (CBV) is maintained during surgery. Consequently,
so-called individual goal-directed fluid therapy aims at
maintaining a CBV that does not limit, e.g. stroke volume
(SV) during surgery, eventually based on a report of SV by
minimally invasive apparatus [5, 7].
We considered that plasma atrial natriuretic peptide
(ANP) would indicate whether filling of the heart is
maintained during surgery. ANP – but not “brain” natri-
uretic peptide [8] - reacts rapidly to a reduction in CBV,
e.g. during head-up tilt [9] or sitting or standing up [8]
as with pressure breathing [10] demonstrating independ-
ence of even a large increase in central venous pressure
[11]. Compared to plasma ANP, plasma pro-ANP
(proANP) is stable with a half-life of 60–120 min [12]
and during cystectomy, plasma proANP decreases with
the perioperative blood loss and, conversely increases
with a positive fluid balance when administration is
based mainly on lactated Ringer’s solution (LR) [13].
We determined plasma proANP and perioperative
fluid balance during open (OE) and robot-assisted hybrid
(RE) esophagectomy. During esophagectomy CBV could
be compromised not only by an eventual blood loss but
also by, e.g. epidural analgesia during OE and head-up
tilt and abdominal CO2 insufflation during RE. We hy-
pothesized that plasma proANP would decrease when
CBV is compromised during the abdominal part of RE
and that a positive fluid balance would be required to
maintain plasma proANP when fluid administration is
based mainly on LR.
Methods
This prospective non-randomized study was a secondary
data analysis of a clinical trial directed to monitor gastric
microcirculation during RE and OE esophagectomy
(ClinicalTrials.gov, ID: NCT02077673) [14] as approved
by the Scientific Ethical Committees, Capital Region,
Denmark (H-2-2013-101). Patients were consecutively
included between December 2013 and April 2015. Oral
and written informed consent was provided at least
1 day before surgery. All patients with biopsy verified
adenocarcinoma of the gastroesophageal junction eli-
gible for a two-stage procedure with an abdominal and a
thoracic part (Ivor Lewis esophagectomy) [15] were
candidates for the study (Table 1). Data were collected
by the investigators and remained confidential through-
out the trial. Patients were excluded from the study if
consent was withdrawn or disseminated disease was evi-
dent, i.e. only patients for whom the operation was com-
pleted were included.
Anesthesia and interventions
An i.v. line was established followed by a thoracic epi-
dural catheter (Th7-Th9) and its position was evaluated
with the response to administration of 3 ml 2% lidocaine
with adrenaline (SAD, Amgros I/S, Denmark). Induction
of anesthesia was with propofol (2.0 mg/kg) and remi-
fentanil (0.5 μg/kg) followed by placement of a double-
lumen endobronchial tube after neuromuscular blockade
by cisatracurium. Anesthesia was maintained by propo-
fol (5–10 mg/kg/h) and remifentanil (1.75–2.25 mg/h)
and ventilation was adjusted to an end-tidal CO2 tension of
28–32 mmHg (Dräger CATO; M32040, Lübeck, Germany).
Guided by ultrasound a central venous catheter was estab-
lished via the right jugular vein for infusion of fluids and, if
considered necessary vasopressors (Table 2). LR (3 ml/kg/
h) was supplemented by 5% Voluven® or human albumin
5% if considered in need by the anesthesiologist. Red blood
cells were administered when hemoglobin was lower than
4.5 or 5.5 mmol/l if the patient was known with cardio-
pulmonary disease. For epidural anesthesia 4 ml bupiva-
caine (5 mg/ml, SAD) was administered before start of the
procedure in both groups. Analgesia was maintained with
bupivacaine (4 ml/h) with morphine (comb. 2.5 mg and 50
microgram/ml, SAD, Amgros I/S, Denmark) before start of
Table 1 Patient characteristics for patients undergoing robot-
assisted hybrid (RE) or open esophagectomy (OE)
RE (n = 25) OE (n = 25) P-value
Age, years 64.8 (±10.4) 68 (±7.9) 0.1
Male sex, n (%) 22 (88.0) 20 (80.0) 0.5
BMI, kg/m2 25.2 (±3.3) 25.8 (±5.1) 0.15
Alcohol, earlier abuse, n (%) 3 (12.0) 2 (8.0) 1.0
Tobacco, current & former, n (%) 22 (88.0) 22 (88.0) 1.0
ASA-classification ≥3, n (%) 5 (20.0) 12 (48) 0.04
Hypercholesterolemia, n (%) 1 (4.0) 7 (28.0) 0.03
Hypertension, n (%) 10 (40.0) 12 (48.0) 0.6
Diabetes, n (%) 5 (20.0) 8 (32.0) 0.4
Heart disease, n (%) 1 (4.0) 3 (12.0) 0.7
Pulmonary disease, n (%) 1 (4.0) 5 (20.0) 0.1
Duration of procedure, minutes 254 (±34.0) 239 (±41.0) 0.9
LOS, days 13 (±7.0) 15 (±8.0) 0.3
BMI body mass index, ASA American Society of Anesthesiologists classification,
LOS length of hospital stay. Heart disease: ischemic heart disease, arrhythmias,
and valve insufficiency. P-values by univariate analyses. Values are mean with
standard deviation (SD) unless stated otherwise
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laparotomy in the OE-group and before the thoracotomy
in the RE-group.
The OE patients were supine during the abdominal
part of the procedure while RE patients were tilted 15°
head-up for use of a da Vinci System (5.0 robotic, Intuitive
Surgical Inc., Sunnyvale, CA, USA). The thoracotomy was
on the right side in left-lateral decubitus position.
Heart rate (HR), SV, mean arterial pressure (MAP),
cardiac output (CO), and systemic vascular resistance
(SVR) were monitored by modified Model flow technol-
ogy (Nexfin®, BMEYE B.V., Amsterdam, The Netherlands)
through a radial artery catheter in the non-dominant arm
[16]. Markers in the Nexfin file were: A after induction of
anesthesia (baseline); B following laparotomy (OE) or
pneumoperitoneum (RE); C 15 min after start of the pro-
cedure; D after mobilization of the stomach, and E follow-
ing abdominal closure (OE) or CO2 desufflation (RE); F
following the gastric remnant pull to the thorax; G forma-
tion of the anastomosis, and H following closure of the
thorax. Also, arterial blood samples were obtained at each
of these events for determination of plasma proANP. The
samples were centrifuged at 3000 rpm for 10 min at 4 °C
and plasma stored at −80 °C until analysis.
Fluid balance was calculated following closure of the
thorax: LR, human albumin 5%, Voluven®, packed red
blood cells, and medicine vs. the blood loss and diuresis.
Also, a separate balance for colloid and crystalloids was
estimated.
Plasma proANP
Plasma proANP was measured with an automated
method from Thermo-Fisher (the Kryptor Plus platform)
that directs antibodies against epitopes within the mid-
region of the precursor [17] and is validated with excel-
lent performance in non-heart failure patients against a
gold standard immunoassay [18–20].
Statistics
Statistics was carried out by IBM SPSS® version 22.0.0
(SPSS, Inc., IL, USA) and graphs constructed (Graph
Pad Software Inc., CA, USA). Baseline characteristics
were evaluated with chi-square or Fisher’s exact test for
nominal variables and t-test and Mann–Whitney U-test
for continuous variables depending on whether data
were normally distributed. To assess changes in plasma
proANP vs. fluid balance linear regression analysis was
used. Changes in hemodynamic variables and in plasma
proANP during surgery were analyzed using the Friedman’s
test. Post hoc comparisons with Bonferroni correction
were applied if the initial test was significant. Values
are expressed as mean with standard deviation or me-
dians with interquartile range (IR) and a p-value ≤0.05
was considered statistical significant.
Results
For RE 25 patients were enrolled consecutively and there
were 26 patients in the OE-group, but one OE patient
was excluded because the procedure was changed to
total gastrectomy. Patients in the OE group demon-
strated a higher ASA-score ≥ 3 (p = 0.04) and a higher
prevalence of hypercholesterolemia (p = 0.03) (Table 1).
Fluid balance and hemodynamics
The intraoperative blood loss was 250 ml (150–375 IR) in
the RE-group and 600 ml (390–855) during OE (p = 0.01),
while fluid administration was similar (2500 (2150–2825)
and 2600 ml (2400–3166), respectively) (p = 0.20, Table 2).
Thus, the fluid balance was positive by 1705 (1390–1983)
(RE) and 1528 ml (1316–1834) (OE), p = 0.40.
Hemodynamic variables during the procedures are
presented in Fig. 1. In the RE-group CO (p = 0.02) and
HR (p < 0.01) increased from induction of pneumoperito-
neum (B) to mobilization of the stomach (D). Meanwhile
SV decreased (p < 0.01) and SVR increased after pneumo-
peritoneum was established (p = 0.04) but returned to
baseline 15 min after start of the procedure (C) (p = 0.04)
at a stable MAP (p = 1.00). Following CO2 desufflation (E)
and termination of head-up tilt, MAP (p = 0.02), SV (p <
0.01), and CO (p < 0.01) increased while HR decreased (p
= 0.01) leaving SVR stable (p = 1.00). During the thoracic
part of the procedure MAP (p = 0.05), CO (p < 0.01), SV
(p = 0.04), and HR (p = 0.02) decreased towards baseline
levels, while SVR was stable (p = 0.31). However, SV (p =
0.01) increased following closure of the thorax.
During OE, HR (p < 0.01), SV (p = 0.05) and thus CO
(p < 0.01) increased from baseline (A) to 15 min after start
of the procedure (C). MAP remained stable (p = 0.70) and
Table 2 Perioperative fluid administration during open (OE) and
robot-assisted esophagectomy (RE)
OE (n = 25) RE (n = 25) P-value
Fluid administration, mla 2600 (2400–3166) 2500 (2150–2825) 0.2
Electrolytes, mlb 1993 (1725–2475) 2000 (1700–2300) 0.7
Human albumin, Voluven
& PRBC, ml
500 (500–938) 500 (250–750) 0.2
Ephedrine, mg 2.5 (0–14) 5.0 (0–13) 0.9
Phenylephrine, mg 0.1 (0–0.3) 0.2 (0–0.4) 0.9
Vasopressor infusion,
ml/min
0.14 (0.1–0.2) 0.12 (0.1–0.2) 0.6
Fluid loss, mlc 1018 (839–1345) 655 (445–1065) 0.01
Blood loss, ml 600 (390–855) 250 (150–375) 0.01
Diuresis, ml 410 (296–599) 345 (300–490) 0.5
Fluid balance, mld 1528 (1316–1834) 1705 (1390–1983) 0.4
Values are medians with interquartile range. P-values by Mann–Whitney U-test.
aFluid administered during anesthesia including medicine and packed red
blood cells (PRBC), bprimarily lactated Ringer’s solution, cFluid loss = diuresis
and blood loss, dFluid balance = fluid infusion – fluid loss. For vasopressor infusion
norepinephrine or phenylephrine were used
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Fig. 1 Hemodynamic variables and plasma proANP during esophagectomy. Values are mean +/− SEM. ○ No change. *Different from previous
value, p < 0.05. ● Different from ‘baseline’ , p < 0.05. ■ Different from ‘CO2 desufflation/abdominal closure’ , p < 0.05. ▲ Different from
’15 min’ , p < 0.05
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hence SVR decreased (p = 0.02). By abdominal closure HR
(p = 0.02), CO (p < 0.01), and SV (p = 0.18) decreased to-
wards baseline levels. MAP (p = 0.73) was stable and
therefore SVR increased (p = 0.01). During the thoracic
part of the procedure SVR (p = 0.01) decreased by gastric
remnant pull with a concomitant increase in HR (p < 0.01)
and CO (p < 0.01). Hemodynamic variables remained at
these levels until closure of the thorax. There was no sig-
nificant difference in vasopressor administration between
the two groups of patients (Table 2).
Plasma proANP
In the OE-group plasma proANP decreased by 11% (p =
0.01) during the abdominal part of the procedure, but by
21% in the RE-group (p < 0.01). During the thoracic part
of the procedure plasma proANP remained stable in the
OE-group (p = 1.00), but increased in the RE-group from
CO2 desufflation (E) to gastric remnant pull (F) (p =
0.01) (Table 3 and Fig. 1). However, plasma proANP was
lower at thoracic closure (H) than at baseline (A) in the
RE-group (p = 0.01). Linear regression between plasma
proANP and fluid balance showed an r-value of 0.4
((−0.045–0.833), p = 0.08) in the OE-group and 0.5
((0.073–0.840), p = 0.02) for the RE patients (Fig. 2).
Discussion
Plasma proANP was determined repetitively during sur-
gery to allow for a distinction between the abdominal
and thoracic part of Ivor Lewis esophagectomy for which
CBV could be compromised by the head-up tilt used for
the abdominal part of the robot-assisted procedure [11, 21].
In fact, plasma proANP decreased twice as much during
the abdominal part of RE (by 21%) than during OE (by
11%) despite fluid balance was positive by about 1700 ml
(by the end of surgery) in both groups and the blood loss
largest during OE (600 vs. 250 ml). Furthermore, plasma
proANP, MAP, and CO increased while HR decreased after
CO2 desufflation and termination of head-up tilt. Together,
these observations support that CBV is reduced during
surgery and especially so if there is a restrain on venous
return to the heart by head-up tilt and abdominal CO2
insufflation.
The ratio between the interstitial fluid space and
plasma is about 1:5 and it is assumed that only 20–25%
of the administered LR remains in plasma [22, 23] and a
separate calculation for the administered crystalloid and
colloid was conducted (Table 2). If 25% of the adminis-
tered 2000 ml of LR is taken to remain within the vessels
together with 5% albumin/voluven® and red blood cells,
the intravascular fluid balance would be +350 ml in the
RE-group and −20 ml for the OE-group. Thus, the patients
were on average close to “normovolemic” by the end of
surgery supported by stable hemodynamic variables during
the thoracic procedure and increasing plasma proANP
Table 3 Plasma proANP during robot-assisted (RE) and open
esophagectomy (OE)
RE (pmol/L, n = 25) OE (pmol/L, n = 25)
Baseline 95 (64–125) 135 (102–161)
Pneumoperitoneum/
Laparotomy
91 (60–119) 118 (94–168)
15 min after start of procedure 83 (59–114) 133 (96–173)
Mobilization of the stomach 81 (55–102) 123 (95–158)
CO2 desufflation/abdominal
closure
74 (53–99)a 120 (82–157)b
Gastric remnant pull 89 (58–117)c 115 (88–158)
Anastomosis 87 (57–122) 101 (78–157)
Closure of the thorax 85 (56–119)b 104 (87–155)
Values are medians with interquartile range. P-values by Friedman’s test
ap < 0.01 different from baseline within the group
bp = 0.01 different from baseline within the group
cp = 0.01 different from ‘CO2 desufflation’ within the group
Fig. 2 Plasma ProANP in relation to fluid balance during open (OE) and
robot assisted esophagectomy (RE). Change in plasma proANP from
start (baseline) to end of surgery (closure of the thorax). Regression line
with 95% CI. Horisontal broken line indicates no change in proANP
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(Table 3). Yet, from determination of plasma proANP, the
patients seemed functional hypovolemic during the ab-
dominal part of the procedure and more so in the RE-
group that was exposed to head-up tilt combined with
pneumoperitoneum. Thus, plasma proANP normalized
when the RE patients were prepared for thoracic surgery,
although plasma proANP did not reach the baseline value.
In a similar study, plasma proANP was followed during
open (ORC) and robot-assisted cystectomy (RARC) [13].
Plasma proANP decreased by 23% in the ORC-group with
a 1500 ml positive fluid balance. Furthermore, plasma
proANP correlated to fluid balance. Also, plasma proANP
did not change for the RARC group, probably reflecting
that the patients were head-down tilted and the blood loss
was minimal.
As estimated by linear regression, a positive fluid bal-
ance by approximately 2400 (RE) and 2000 ml (OE)
seemed to be required to keep plasma proANP stable
during surgery (Fig. 2), i.e. approximately 600 ml more
than was administered. Similarly for patients undergoing
laparoscopic cholecystectomies in a head-up tilted pos-
ition [1], improvement was found for pulmonary function,
exercise capacity, nausea, and dizziness for patients ad-
ministered 40 ml/kg LR (approx. 3000 ml) compared to
15 ml/kg (approx. 1000 ml). Yet, it remains to be deter-
mined whether more fluid should be administered during
head-up tilted major abdominal procedures to prevent
functional hypovolemia, i.e. whether it favors outcome
including microcirculation to the anastomotic area and re-
duction in hypotensive episodes during surgery. On the
other hand, excess fluid administration can lead to inter-
stitial edema, impaired tissue healing with impact of anas-
tomotic healing and also cardiopulmonary complications
representing a risk factor [3, 24, 25].
Epidural anesthesia reduces SVR [26] due to sympatho-
lysis as observed in the OE-group while SVR remained
stable in the RE-group, besides a transitory increase
may be due to CO2 insufflation with release of hor-
mones like noradrenalin, compression of the splanchnic
organs, and CO2 absorbed from the peritoneal cavity
[27, 28]. Moreover, traction of the viscera can stimulate
release of vasoactive hormones like prostacyclin cor-
roborating a decrease in SVR, more prevalent during
open than laparoscopic surgery [29–31].
This study was based on a secondary analysis of pro-
spective data in a non-randomized design and selection
bias should be considered. The two groups of patients
demonstrated different baseline plasma proANP (Table 3)
maybe related to that the ASA score was higher in the
OE group and not acknowledged heart disease may have
been overrepresented [32] supported by a higher preva-
lence of hypercholesterolemia. Thus, we cannot rule out
that patients presenting co-morbidity have been selected
for the “conservative” OE procedure although the primary
criterion for selection of OE or RE was based on the
access to the daVinci System.
We accept that this report is only the second to evalu-
ate fluid balance during surgery in relation to plasma
proANP and that a wider database is needed to guide
inter-operative fluid therapy on its influence on plasma
proANP. However, we find it of interest to add a biomarker
to evaluation of perioperative fluid balance presently mainly
based on a predefined fluid regime supplemented by re-
cording of physiological variables. Furthermore, we ac-
knowledge that other measures of CO like transesophageal
echocardiography [33], thoracic electrical impedance [34],
and central venous oxygen saturation [35] can be obtained
for assessment of CBV and may be required to generalize
the findings of this study.
Conclusion
This study showed a marked decrease in plasma proANP
during the abdominal part of esophagectomy supporting
that CBV is compromised during surgery and especially so
for laparoscopic procedures including head-up tilt. We
demonstrated a correlation between plasma proANP and
perioperative fluid balance based mainly on LR. Taking
plasma proANP to indicate filling of the heart, the data
support that plasma proANP is a marker of fluid balance
during surgery. Based on that idea, a fluid surplus by about
2200 ml would be required to maintain plasma proANP
during esophagectomy. Yet, it needs to be evaluated
whether a perioperative fluid regime directed to maintain
plasma proANP improves outcome after surgery.
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